Cargando…
Radioiodine treatment of differentiated thyroid cancer despite history of ‘iodine allergy’
Radioiodine ((131)I) is a critical component in the treatment of differentiated thyroid cancer. We recently saw a patient with thyroid cancer who was hesitant to take (131)I treatment because he had previously encountered an allergic reaction to administration of iodine-containing radiocontrast agen...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bioscientifica Ltd
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965283/ https://www.ncbi.nlm.nih.gov/pubmed/24683486 http://dx.doi.org/10.1530/EDM-13-0084 |